The portal "botasot.info" has published an article titled "From October there will be no more free tests for CoVID-19".
A fact check conducted by hibrid.info shows that the article contains a general title, as it does not specify which country has made such a decision. The clarification is made only in the content, stating that the news is about the country of Switzerland.
Knowing that this portal is in Albanian and that most of its readers are Kosovars, it is implied that this decision is about Kosovo.
Excerpt from the text of the article published on "botasot.info":
From October there will be no more free tests for CoVID-19
The Swiss Federal Council met today for its first meeting after the summer break, writes Blick.ch, reports "Bota sot".
The focus of the meeting was the price of the test and the transition to the normalization phase.
The normalization phase is being considered the last of the three-phase model with which the Federal Council outlined the path out of the pandemic in April.
Link to the article published on "botasot.info":
Analyze:
The "botasot.info" portal has published an article regarding a decision stating that from October, corona tests in Switzerland will no longer be free for people without symptoms, while the title does not clarify which country it is referring to.
This suggests that the news is about Kosovo, knowing that this medium is registered in our country and the majority of the audience is from the same country.
After fact-checking based on the work methodology, hibrid.info assesses this article as "clickbait".
Reasoning:
The “Clickbait” rating is given to texts whose titles have no basis in the content of the following text. Such texts and articles aim to attract the attention of the reader or even the consumer with a sensational title by promising content that does not actually exist and are created mainly out of financial interest, that is, due to increased readability. So, this type of text is intended only to click, which can be converted into a profit for the content producer.